Galena Biopharma - Zuplenz - Ownership and Business Overview

Medical ProductsCompany

Galena Biopharma - Zuplenz Ownership

Who owns Galena Biopharma - Zuplenz?

Galena Biopharma - Zuplenz is owned by Midatech Pharma. It was acquired on December 30, 2015.

Galena Biopharma - Zuplenz Business Overview

Where is Galena Biopharma - Zuplenz headquartered?

Galena Biopharma - Zuplenz is headquartered in United States.

What sector is Galena Biopharma - Zuplenz in?

Galena Biopharma - Zuplenz is a medical products company.

Medical Products M&A Summary in 2015

Out of 60 sectors in the Mergr database, medical products ranked 10 in number of deals in 2015. The largest medical products acquisition in 2015 was Sirona Dental Systems - which was acquired by Dentsply Sirona for $5.6B.

Subscribe to Mergr to view all 269 acquisitions of medical products companies in 2015, including 26 acquisitions by private equity firms, and 243 by strategics.

Galena Biopharma - Zuplenz


United States,
(855) 636-5710
www.zuplenz.com

Galena Biopharma - Zuplenz® (ondansetron) Oral Soluble Film, is approved by the U.S. Food and Drug Administration for use in adult patients for the prevention of highly and moderately emetogenic chemotherapy-induced nausea and vomiting (CINV), radiotherapy-induced nausea and vomiting (RINV), and post-operative nausea and vomiting (PONV)


 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for Galena Biopharma - Zuplenz

Medical Products Companies